LEP and obesity disorder: Abnormalities in adipokine production (e.g., a decrease in adiponectin and an increase in leptin or pro-inflammatory cytokines) contribute to the development and progression of obesity, insulin resistance, type 2 diabetes, and cardiovascular complications.